SomaLogic Investor Relations Material
Latest events
Q3 2023
SomaLogic
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from SomaLogic Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Assay services revenue
Product revenue
Collaboration revenue
Other
Expenses by
Financials
SomaLogic, Inc. offers proteomics technologies and scientific expertise that enable high-throughput, large-scale measuring of multiple proteins in biological samples. The company provides data analysis tools through contract research organizations and translational research collaborators in the academic, biotechnology, pharmaceutical, diagnostics, and food industries. It offers PROTEOME1S and PRTOM1S products for measuring a range of approximately 1,200 human proteins in urine; and SOMAmer reagents that are used to measure human proteins from blood samples. SomaLogic also owns and maintains an ultrahigh-frequency radio transmitter; and data link operation that allows communication among the connected aircraft fleets
Key slides for SomaLogic Inc
Business Combination
SomaLogic Inc
Business Combination
SomaLogic Inc
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
SLGC
Country
🇺🇸 United States